… The ISHLT listing criteria acknowledges diversity of pre-existing malignancies and … .
Temporal trends of de novo malignancy development after heart transplantation. J Am Coll Cardiol …

… Donor hearts are susceptible to complement-dependent ischemia/reperfusion injury after
transplant, 15 and higher levels of donor tumor necrosis factor (TNF)-α have been associated …

… , linked to 4 national cardiac audits (myocardial Infarction, heart failure, cardiac surgery, and
… data to determine the prevalence of pre-existing CVD in a national cohort of cancer patients. …

… after the first-year post-LT is liver related in up to 28% of patients, non-hepatic causes of death
are increasing with malignancies (… % of patients, particularly de novo tumours and CVD.8 …

… in heart transplant recipients may be due to pre-existing … de novo malignancy development
after heart transplantation. … infection and skin cancer risk in organ transplant recipients. J …

… to developing subsequent cancers which can be amplified by … transplant malignancy was
associated with an increased risk … -transplant malignancy with a total of 328 cancer diagnoses. …

… malignancies transplanted between 2010 and 2018 from matched sibling and unrelated
donors with a full data set of pre-existing … donor for hematologic malignancy reported to the …

… such as age at transplant, comorbid conditions, prior cardiotoxic cancer treatments, type of
HSCT… (age at transplant, sex, and race), medical history, pre-existing CV risk factors (history of …

… The contemporary risk of de novo solid malignancy between … effects and pre-existing cancer
risk factors. The interplay of … increased cancer-specific mortality for the majority of cancers …

… Pre-existing cardiovascular disease, heart failure and type 2 … rate of 12.7% malignancies
within the first transplant year [24]… , liver or heart transplants, post-transplant infections were …